International Psychotropic Substances Act

International Psychotropic Substances Act - Provides that whenever the Secretary of State receives notification from the Secretary General of the United Nations that information has been transmitted by or to the World Health Organization, pursuant to the Convention on Psychotropic Substances, which may justify adding a drug or other substance to one of the schedules of the convention, transferring a drug or substance from one schedule to another, or deleting it from the schedules, the Secretary of State shall immediately transmit the notice to the Secretary of Health, Education, and Welfare. States that the Secretary shall prepare for transmission through the Secretary of State to the World Health Organization such medical and scientific evaluations as may be appropriate regarding the possible action that could be proposed by the World Health Organization.

Provides that, if the Attorney General determines, in view of exceptional circumstances, that the United States will not be in a position to give effect to all of the provisions of the Convention on Psychotropic Substances applicable to that drug or substance, he shall transmit notice of his determination and the reasons therefor to the Secretary of State for transmittal to the Secretary General of the United Nations within the time required by the convention.

Provides that, upon completion of proceedings for control in accordance with this Act, the Attorney General shall issue a final order controlling the drug or substance under the appropriate schedule as determinined by such proceedings.

States that every manufacturer registered under the Controlled Substances Act at such time or times and in such form as the Attorney General may require, make periodic reports to the Attorney General with respect to non-narcotic-controlled substances which are physchotropic substances subject to the Convention on Psychotropic Substances, signed in Vienna, February 21, 1971.

Specifies that nothing in the Convention on Psychotropic Substances, or other international treaties or agreements shall be construed to limit, modify, or prevent the protection of the confidentiality of patient records or of the names and other identifying characteristics of research subjects as provided by any Federal, State, or local enactment or regulation.

Provides that nothing in the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, or other treaties or international agreements shall be construed to require a specific punishment for conduct involving narcotic drugs or psychotropic substances or to limit the provision of such treatment, education, aftercare, rehabilitation, and social reintegration or other alternatives to arrest, prosecution, conviction or punishment for such conduct as may be authorized by any Act of Congress.